======= PFKL =======
== Gene Information ==
* **Official Symbol**: PFKL
* **Official Name**: phosphofructokinase, liver type
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5211|5211]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P17858|P17858]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PFKL&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PFKL|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/171860|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes the liver (L) subunit of an enzyme that catalyzes the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate, which is a key step in glucose metabolism (glycolysis). This enzyme is a tetramer that may be composed of different subunits encoded by distinct genes in different tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014].
* **UniProt Summary**: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. {ECO:0000255|HAMAP-Rule:MF_03184, ECO:0000269|PubMed:22923583}.
|PFK|
|6-phosphofructokinase complex|
|6-phosphofructokinase activity|
|fructose binding|
|fructose-6-phosphate binding|
|fructose 6-phosphate metabolic process|
|fructose 1,6-bisphosphate metabolic process|
|AMP binding|
|monosaccharide binding|
|NADH regeneration|
|glucose catabolic process to pyruvate|
|canonical glycolysis|
|glycolytic process through glucose-6-phosphate|
|glycolytic process through fructose-6-phosphate|
|glucose catabolic process|
|NADH metabolic process|
|negative regulation of insulin secretion|
|glycolytic process|
|ATP generation from ADP|
|negative regulation of peptide hormone secretion|
|NAD metabolic process|
|ADP metabolic process|
|hexose catabolic process|
|nucleoside diphosphate phosphorylation|
|purine ribonucleoside diphosphate metabolic process|
|nucleotide phosphorylation|
|purine nucleoside diphosphate metabolic process|
|monosaccharide catabolic process|
|negative regulation of hormone secretion|
|ribonucleoside diphosphate metabolic process|
|pyruvate metabolic process|
|nucleoside diphosphate metabolic process|
|kinase binding|
|protein homotetramerization|
|glucose metabolic process|
|secretory granule lumen|
|carbohydrate catabolic process|
|ficolin-1-rich granule lumen|
|negative regulation of protein secretion|
|response to glucose|
|negative regulation of peptide secretion|
|response to hexose|
|response to monosaccharide|
|protein tetramerization|
|hexose metabolic process|
|response to carbohydrate|
|regulation of insulin secretion|
|negative regulation of protein transport|
|negative regulation of establishment of protein localization|
|monosaccharide metabolic process|
|negative regulation of secretion by cell|
|ATP metabolic process|
|regulation of peptide hormone secretion|
|negative regulation of secretion|
|regulation of hormone secretion|
|purine ribonucleotide metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|protein homooligomerization|
|purine-containing compound metabolic process|
|generation of precursor metabolites and energy|
|small molecule catabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|regulation of protein secretion|
|carbohydrate metabolic process|
|negative regulation of transport|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|regulation of peptide secretion|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|protein complex oligomerization|
|myeloid cell activation involved in immune response|
|monocarboxylic acid metabolic process|
|regulation of hormone levels|
|nucleobase-containing small molecule metabolic process|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|regulated exocytosis|
|regulation of protein transport|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|leukocyte mediated immunity|
|exocytosis|
|regulation of secretion|
|organophosphate metabolic process|
|carboxylic acid metabolic process|
|leukocyte activation|
|oxidation-reduction process|
|oxoacid metabolic process|
|secretion by cell|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|regulation of protein localization|
|export from cell|
|identical protein binding|
|cell activation|
|immune effector process|
|secretion|
|phosphorylation|
|negative regulation of cell communication|
|negative regulation of signaling|
|ATP binding|
|response to oxygen-containing compound|
|protein-containing complex assembly|
|small molecule metabolic process|
|organic substance catabolic process|
|protein-containing complex subunit organization|
|regulation of transport|
|immune response|
|extracellular region|
|vesicle-mediated transport|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.87|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2692
* **Expression level (log2 read counts)**: 7.67
{{:chemogenomics:nalm6 dist.png?nolink |}}